|
1
|
De Manzoni G, Marrelli D, Baiocchi GL,
Morgagni P, Saragoni L, Degiuli M, Donini A, Fumagalli U, Mazzei
MA, Pacelli F, et al: The italian research group for gastric cancer
(GIRCG) guidelines for gastric cancer staging and treatment: 2015.
Gastric Cancer. 20:20–30. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Sabanathan D, Eslick GD and Shannon J: Use
of neoadjuvant chemotherapy plus molecular targeted therapy in
colorectal liver metastases: A Systematic review and meta-analysis.
Clin Colorectal Cancer. 15:e141–e147. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Robinson SM, Mann J, Vasilaki A, Mathers
J, Burt AD, Oakley F, White SA and Mann DA: Pathogenesis of FOLFOX
induced sinusoidal obstruction syndrome in a murine chemotherapy
model. J Hepatol. 59:318–326. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Valla DC and Cazals-Hatem D: Sinusoidal
obstruction syndrome. Clin Res Hepatol Gastroenterol. 40:378–385.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Fan CQ and Crawford JM: Sinusoidal
obstruction syndrome (hepatic veno-occlusive disease). J Clin Exp
Hepatol. 4:332–346. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Plessier A, Rautou PE and Valla DC:
Management of hepatic vascular diseases. J Hepatol. 56 Suppl
1:S25–S38. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Rubbia-Brandt L, Audard V, Sartoretti P,
Roth AD, Brezault C, Le Charpentier M, Dousset B, Morel P, Soubrane
O, Chaussade S, et al: Severe hepatic sinusoidal obstruction
associated with oxaliplatin-based chemotherapy in patients with
metastatic colorectal cancer. Ann Oncol. 15:460–466. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Han NY, Park BJ, Kim MJ, Sung DJ and Cho
SB: Hepatic parenchymal heterogeneity on contrast-enhanced ct scans
following oxaliplatin-based chemotherapy: Natural history and
association with clinical evidence of sinusoidal obstruction
syndrome. Radiology. 276:766–774. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Han NY, Park BJ, Sung DJ, Kim MJ, Cho SB,
Lee CH, Jang YJ, Kim SY, Kim DS, Um SH, et al: Chemotherapy-induced
focal hepatopathy in patients with gastrointestinal malignancy:
Gadoxetic acid-enhanced and diffusion-weighted MR imaging with
clinical-pathologic correlation. Radiology. 271:416–425. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Shin NY, Kim MJ, Lim JS, Park MS, Chung
YE, Choi JY, Kim KW and Park YN: Accuracy of gadoxetic
acid-enhanced magnetic resonance imaging for the diagnosis of
sinusoidal obstruction syndrome in patients with
chemotherapy-treated colorectal liver metastases. Eur Radiol.
22:864–871. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Ward J, Guthrie JA, Sheridan MB, Boyes S,
Smith JT, Wilson D, Wyatt JI, Treanor D and Robinson PJ: Sinusoidal
obstructive syndrome diagnosed with superparamagnetic iron
oxide-enhanced magnetic resonance imaging in patients with
chemotherapy-treated colorectal liver metastases. J Clin Oncol.
26:4304–4310. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Anurathapan U, Pakakasama S, Mekjaruskul
P, Sirachainan N, Songdej D, Chuansumrit A, Charoenkwan P,
Jetsrisuparb A, Sanpakit K, Pongtanakul B, et al: Outcomes of
thalassemia patients undergoing hematopoietic stem cell
transplantation by using a standard myeloablative versus a novel
reduced-toxicity conditioning regimen according to a new risk
stratification. Biol Blood Marrow Transplant. 20:2066–2071. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Li X, Yang X, Xu D, Li Q, Kong X, Lu Z,
Bai T, Xu K, Ye J and Song Y: Magnetic resonance imaging findings
in patients with pyrrolizidine alkaloid-induced hepatic sinusoidal
obstruction syndrome. Clin Gastroenterol Hepatol. 15:955–957. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Kan X, Ye J, Rong X, Lu Z, Li X, Wang Y,
Yang L, Xu K, Song Y and Hou X: Diagnostic performance of
contrast-enhanced CT in pyrrolizidine alkaloids-induced hepatic
sinusoidal obstructive syndrome. Sci Rep. 6:379982016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
DeLeve LD: Liver sinusoidal endothelial
cells and liver regeneration. J Clin Invest. 123:1861–1866. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
ORourke TR, Welsh FK, Tekkis PP, Lyle N,
Mustajab A, John TG, Peppercorn D and Rees M: Accuracy of
liver-specific magnetic resonance imaging as a predictor of
chemotherapy-associated hepatic cellular injury prior to liver
resection. Eur J Surg Oncol. 35:1085–1091. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Choi JH, Won YW, Kim HS, Oh YH, Lim S and
Kim HJ: Oxaliplatin-induced sinusoidal obstruction syndrome
mimicking metastatic colon cancer in the liver. Oncol Lett.
11:2861–2864. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Arakawa Y, Shimada M, Utsunomya T, Imura
S, Morine Y, Ikemoto T, Hanaoka J, Sugimoto K and Bando Y:
Oxaliplatin-related sinusoidal obstruction syndrome mimicking
metastatic liver tumors. Hepatol Res. 43:685–689. 2013. View Article : Google Scholar : PubMed/NCBI
|
